Clinical Trials Browser

Phase 2 × Thyroid Carcinoma, Anaplastic × Imatinib Mesylate × Clear all

NCT00115739 2014-04-21

Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma

Phase 2 Terminated

11 enrolled 10 charts

EndocrineHead & Neck

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic